Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnold R Eiser

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
The American Journal of Medicine|June 21, 2016
The ReplyArnold R Eiser
The American Journal of Medicine|December 17, 2013
Warfarin, calciphylaxis, atrial fibrillation, and patients on dialysis: outlier subsets and practice guidelinesArnold R Eiser
The American Journal of Medicine|July 13, 2021
The Current State of Pharma and the FDA: Approval of a Dementia Drug as a Case in PointArnold R Eiser
Medical Hypotheses|May 12, 2010
Does over-expression of transforming growth factor-beta account for the increased morbidity in African-Americans?: possible clinical study and therapeutic implicationsArnold R Eiser
The American Journal of Medicine|June 28, 2024
Environmental, Metabolic, and Nutritional Factors Concerning Dementia in African American and Hispanic American PopulationsArnold R Eiser
The American Journal of Medicine|June 3, 2015
Postmodern Stress Disorder (PMSD): A Possible New DisorderArnold R Eiser
Journal of Alternative and Complementary Medicine (New York, N.Y.)|December 10, 2020
Could Dietary Factors Reduce COVID-19 Mortality Rates? Moderating the Inflammatory StateArnold R Eiser
The American Journal of Medicine|April 8, 2024
Mild Cognitive Impairment and the Missed Opportunity to Prevent DementiaArnold R Eiser
The American Journal of Medicine|October 21, 2024
Environmental Neurotoxins and a Neurodegenerative Outbreak: Diagnosis Requires Specific Sampling KnowledgeArnold R Eiser
Brain Research|July 9, 2017
Why does Finland have the highest dementia mortality rate? Environmental factors may be generalizableArnold R Eiser
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
The American Journal of Medicine|June 21, 2016
The ReplyArnold R Eiser
The American Journal of Medicine|December 17, 2013
Warfarin, calciphylaxis, atrial fibrillation, and patients on dialysis: outlier subsets and practice guidelinesArnold R Eiser
The American Journal of Medicine|July 13, 2021
The Current State of Pharma and the FDA: Approval of a Dementia Drug as a Case in PointArnold R Eiser
Medical Hypotheses|May 12, 2010
Does over-expression of transforming growth factor-beta account for the increased morbidity in African-Americans?: possible clinical study and therapeutic implicationsArnold R Eiser
The American Journal of Medicine|June 28, 2024
Environmental, Metabolic, and Nutritional Factors Concerning Dementia in African American and Hispanic American PopulationsArnold R Eiser
The American Journal of Medicine|June 3, 2015
Postmodern Stress Disorder (PMSD): A Possible New DisorderArnold R Eiser
Journal of Alternative and Complementary Medicine (New York, N.Y.)|December 10, 2020
Could Dietary Factors Reduce COVID-19 Mortality Rates? Moderating the Inflammatory StateArnold R Eiser
The American Journal of Medicine|April 8, 2024
Mild Cognitive Impairment and the Missed Opportunity to Prevent DementiaArnold R Eiser
The American Journal of Medicine|October 21, 2024
Environmental Neurotoxins and a Neurodegenerative Outbreak: Diagnosis Requires Specific Sampling KnowledgeArnold R Eiser
Brain Research|July 9, 2017
Why does Finland have the highest dementia mortality rate? Environmental factors may be generalizableArnold R Eiser
Pageof 4